Additional early-stage research and drug discovery news in brief, from: Cereno Scientific, Gri Bio, Palisade Bio, Panavance Therapeutics, Zyversa Therapeutics.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 23andme Holding, Ampersand, Alligator, Exscientia, Flagship, Mirador, Montai, Novartis, Orion, Pfizer, Recursion, Vyriad.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Avant Technologies, Ainnova Tech, Breakthrough Genomics, Cirrusmd, Clinical Microbiomics, Cmbio, Cosmosid, DNASense, Empiramed, Emstop, MS-Omics, Novadip, Storycatch.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aditxt, Appili, Bayer, Beigene, Biolojic, Bristol Myers, Cytokinetics, Intas, Lindis, MSN Pharmaceuticals, Neurogene, Pharmanovia, SK Biopharmaceuticals, Telix, Xbrane.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 23andme, 626, Abbott, Acentus, Ally Medical/Preston Mobility, Bio-Tehne, Bracco, Colowatch, Echolight, Henry Schein, Insulet, Leader Life Sciences, Medtronic, Mirador, Onward Medical, Owkin, Proscia, Siemens Healthineers, Tempus AI.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Aldeyra, Avenzo, HCW, Neurobo, Trogenix, VBI Vaccines, Velavigo, WY Biotech.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alpha Imaging, Astrazeneca, Daiichi Sankyo, Fresneius, Grail, Nephro Group, Radon Medical, Rockwell Medical, Telix..
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: ARS, Alk-Abello, Alfreso, Atsena, Biocytogen, Biontech, Biotheus, CSL, Ideaya, Kaken, Nippon Shinyaku, NS Pharma, Numab, Pediatrix, Qilu, Theravance, Viatris
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adaptimmune, Akari, Evotec, Halozyme, Kaken, Numab, Peak, TFF.